IP Library Granted Patent US 11,510,822
Granted Patent B2
US 11,510,822 · App. 16/474,821 · Granted Nov 29, 2022

Heel patch

Inventors: Ljiljana Sakotic (Greenwood Lake, NY); Matthew J. Clemente (Glen Rock, NJ); Nohora Cárdenas (New Milford, NJ)
Assignee: EUROMED, INC.
A61F13/067A61F13/00063A61K8/0208A61K8/31A61K8/368A61K8/42A61K8/731A61K8/8117A61K8/92A61Q19/007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,510,822
App. No.
16/474,821
Granted
Nov 29, 2022
Kind
B2
Abstract

An improved therapeutic adhesive patch for application to the heel is described for treating or preventing heel disorders or conditions, such as cracked heel.

Claims (33)

1. A flexible adhesive heel patch arrangement comprising:

a flexible adhesive patch comprising:

a backing having two sides;

a therapeutic adhesive composition coated on at least a portion of one side of the backing;

secondary removable liners in contact with the surface of the therapeutic adhesive composition and configured to facilitate application of the heel patch to the heel of a mammal, where the secondary removable liners contact less than the total surface of the surface of the therapeutic adhesive composition; and

a primary release liner completely covering the therapeutic adhesive composition and the secondary removable liners, where the primary release liner contains a means for readily separating the primary release liner into a first and a second portion, with each portion remaining in contact with the adhesive composition.

2. The adhesive heel patch arrangement according to claim 1 , wherein the means for separating is a perforated pattern or a slit that partially or completely penetrates the primary release liner.

3. The adhesive patch arrangement according to claim 1 , wherein the area of the primary release liner is equal to or larger than the area of the therapeutic adhesive composition.

4. The adhesive patch arrangement according to claim 1 , wherein the primary release liner comprises one or more of a polyester film, a polyolefin film or a plastic laminated paper.

5. The adhesive patch arrangement according to claim 1 , wherein the primary release liner has a thickness of about 0.02 mm to about 0.5 mm.

6. The adhesive patch arrangement according to claim 1 , wherein the backing has a thickness of about 0.005 mm to about 1.0 mm.

7. The adhesive patch arrangement according to claim 1 , wherein the backing comprises polycellulose fibers, polyester fibers, polyurethane fibers, polyolefin fibers, polyamide fibers, cotton fibers, copolyester fibers, a polycellulose film, a polyurethane film, a polyester film, a polyethylene film, a polyolefin film or any mixture thereof.

8. The adhesive patch arrangement according to claim 1 , wherein the therapeutic adhesive composition comprises one or more of a polyacrylamide, xanthum gum, guar gum, a hydrocolloid, a starch, a vinyl acetate copolymer, polyvinyl pyrrolidone, polyvinyl alcohol, polyethylene oxide, a polyacrylate, polymaleic acid, polymaleic anhydride, a polyurethane, a polyurea, maltodextrin, carboxymethyl cellulose, carboxypropyl cellulose, a hydrocolloid, a hydrogel, rubber, an acrylic, a silicone, a polyurethane, an emollient, a descaling agent, lactic acid, hydrocortisone, triamcinolone acetonide, betametasone, anthracene, polyethylene, polyvinyl chloride, gelatin, collagen, hexidine, chlorohexamine, sodium chloride, potassium chloride, water, an alcohol, a skin conditioner, an antimicrobial agent, or an antiseptic agent.

9. The adhesive patch arrangement according to claim 1 , wherein the therapeutic adhesive composition has a thickness of about 0.1 mm to about 3 mm.

10. The adhesive patch arrangement according to claim 1 , wherein the therapeutic adhesive composition is thicker at the center than at the edges.

11. The adhesive patch arrangement according to claim 1 , wherein the arrangement has an oval shape.

12. The adhesive patch arrangement according to claim 11 , having a width of 2 to 5 inches and a length of 3 to 7 inches.

13. The adhesive patch arrangement according to claim 1 , wherein the patch arrangement comprises four secondary removable liners that appear at edges of the surface of the therapeutic adhesive composition.

14. A method for attaching the flexible adhesive heel patch arrangement according to claim 1 to the heel of a mammal, the method comprising:

detaching the first portion of the primary release liner from the adhesive patch arrangement to expose a first portion of the adhesive composition surface and the secondary removable liners present underneath the first portion of the liner;

attaching the first portion of the adhesive composition to the bottom of the heel;

removing the secondary removable liners uncovered by the detachment of the first portion of the primary release liner;

attaching the surface of the adhesive composition uncovered by removal of the secondary removable liners in the previous step to both sides of the heel;

detaching the second portion of the primary release liner from the adhesive patch arrangement to expose the remaining portion of the adhesive composition surface and the secondary removable liners present underneath the second portion of the primary release liner;

attaching the second portion of the adhesive composition to the back of the heel;

removing the secondary removable liners uncovered by the detachment of the second portion of the primary release liner; and

attaching the surface of the adhesive composition uncovered by removal of the secondary removable liners in the previous step on top of the patch previously attached to both sides of the heel to complete attachment of the patch to the heel.

15. The method according to claim 14 , wherein the mammal is a human.

16. The method according to claim 14 , wherein the means for separating is a perforated pattern or a slit that partially or completely penetrates the primary release liner.

17. The method according to claim 14 , wherein the area of the primary release liner is equal to or larger than the area of the therapeutic adhesive composition.

18. A method for treating or preventing a disorder or condition of the heel of a mammal, comprising applying to the affected skin surface the flexible adhesive patch arrangement according to claim 1 for an period of time effective to treat or prevent the heel disorder or condition.

19. The method according to claim 18 , wherein the disorder or condition is a heel fissure or a cracked heel.

20. The method of claim 18 wherein the mammal is a human.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2022
From: SAKOTIC, LJILJANA; CLEMENTE, MATTHEW J.; CÁRDENAS, NOHORA
To: EUROMED, INC.
Reel/Frame 061684/0732 →
PATENT SECURITY AGREEMENT Recorded Apr 27, 2022
From: EUROMED, INC.; SCAPA TAPES NORTH AMERICA LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 059810/0690 →
Continuity (2)
Provisional Application 62440952 · Dec 30, 2016
Related Publication 20200121515A1 · Apr 23, 2020